Plans to build the world's biggest biomass power station fuelled by wood chips have been given the go-ahead by the UK government. The £400 million plant to be located in Port Talbot will have the capacity to power not less than half of all homes in Wales. In other words, the station will meet the electricity needs of around 1.5 million people in a sustainable, renewable and carbon-neutral way. When completed, the 350MW biomass plant will produce about 70% of the Welsh Assembly Government's entire 2010 renewable energy target. This makes it the region's single strongest weapon in the fight against climate change.
London-based Prenergy Power Ltd will build the plant in the Port Talbot's docks area after being given the go-ahead by Business Secretary John Hutton of the Department for Business, Enterprise and Regulatory Reform. Port Talbot is an industrial town with a deep water harbor in the traditional county of Glamorgan, south Wales, with a population of approximately 50,000. The project will generate 150 permanent jobs and stimulate the region's economy indirectly.
The renewable energy station will burn about 3 million tonnes of woody biomass shipped in each year from overseas (mainly from the United States and Canada), for the production of certified carbon-neutral electricity. Feedstock production - tree replanting and harvesting - is monitored to happen in a sustainable way. The plant in Port Talbot thus gives a major impulse to the already rapidly growing international biomass market.
The biomass plant has significant advantages compared to the majority of other renewable technologies such as wind power, solar and photovoltaic, which, whilst valuable contributors to combat climate change, are intermittent and can often only operate for 25% to 30% of the year. This requires back-up by other sources, which currently are obtained from fossil fuels. The biofuelled plant on the contrary offers a robust continuous baseload for more than 90% of the year. As such, the forecasting of energy generated by the renewable energy plant is more reliable. Because of this, the UK's national grid can better balance electricity supply with demand and maintain the integrity of the national electricity transmission system.
Clean (virgin, unused) wood chip will be delivered to the development site in 'Panamax' vessels. Each vessel will hold approximately 45,000 tonnes of wood chip and will unload at the existing jetty. New cranes will discharge onto a new conveyor system which will move the wood chip to the fuel storage area.
The biofuel from the fuel storage area will be transferred to a Circulating Fluidised Bed (CFB) boiler by means of an enclosed conveyor belt system from one of three fuel blending silos. The CFB boiler will raise steam for a single 350 MW (electrical) steam turbine. Exhaust steam from this turbine will be condensed by means of a dry air cooled condenser and will therefore require no water for cooling purposes. Condensed steam will then be recirculated back into the CFB boiler.
After combustion, the flue gasses will pass through a fabric filter to remove 99.99% of the entrained dust, and will then flow up a 100 m tall stack designed for optimal flue gas dispersion.
There will be no need for sulphur or chlorine control as the wood fuel does not contain significant quantities of these components. Furthermore, wood ash is inherently alkaline in composition and will capture trace amounts of chlorine, fluorine and sulphur from the exhaust gas. The wood will also have minimal ash content, producing less than 150,000 tonnes per year of ash which will be sold to the cement and fertiliser industry and transported from the Renewable Energy Plant by sea and/or road.
Electricity generated from the Renewable Power Plant will be exported via a new 275 kV underground electrical line to the existing 275 kV electrical substation at Margam around 2 km away.
Despite the many advantages over intermitten renewables, running biomass plants is a balancing act in itself because the feedstocks used are still carbonaceous biofuels which yield local emissions (carbon is taken back up by new tree growth, though) and they have to be physically transported which may affect the local environment.
Different impact assessments were therefor conducted checking the environmental, social and cultural impacts. The air quality impact assessment showed that emissions from the plant will not have a significant effect on air quality for surrounding areas. The PM10 contributions within the Air Quality Management Area (0.08 μg/m3) are considered to be insignificant based on current criteria. A number of mitigation measures have been identified to reduce or remove potential impacts. The model used predicted that cold weather will cause a visible moisture plume at the top of the stack for 14% of the year but his was predicted to be of minor impact.
The height of the tallest building within the development will be 65 metres; the height of the chimney will be 100 metres. Visual impact is therefor in keeping with the surrounding industrial area (existing versus predicted view, click to enlarge).
Prenergy will receive the biofuel for the plant by sea only (or potentially in the future by rail), which is a key transport impact mitigation measure. Furthermore, all operational impacts dealing with the plant have been assessed as 'insignificant'.
Other assessments included a an analysis of impacts on the terrestrial ecology of the region, a flood consequence assessment, an investigation into possible noise pollution coming from the plant and its operations, effects on ground and surface water, and on cultural heritage and communications.
On all fronts, the results published in the Environmental Statement (the formal written statement of the findings of the development's environmental impact assessment) met the criteria and was therefor approved.
Just a week ago, the UK opened its first 'large' biomass power plant, a 30MW station that would run on domestically sourced waste wood and biomass from energy crops. The power station generates electricity for 30,000 homes (previous pots). Another large biomass plant is being built in Lockerbie, Scotland, that will be fuelled by short rotation coppice energy crops. The £90 (€133/US$178) million E.ON facility is expected to be fully operational by the end of the year and will generate enough electricity to power 70,000 homes, provides over 300 jobs in the forestry and energy farming sector, and displaces the emission of 140,000 tonnes of greenhouse gases each year (more here).
According to the UK's recently published Biomass Strategy, there is a large potential for both domestically and internationally sourced bioenergy. Biomass, biofuels and bioproducts are therefor set to play a major role in the UK's bid to meet the EU target of producing 20 percent of energy from renewables by 2020. The country's long-term strategy was expresed in the Climate Change Bill, published in draft in March 2007, which sets out a proposed UK target of at least 60% cuts in carbon dioxide emissions by 2050 and a strong new system of carbon budgeting.
Prenergy Power: Port Talbot Renewable Energy Plant website.
Prenergy Power: Port Talbot Renewable Energy Plant, non-technical summary [*.pdf].
Reuters: World's biggest biomass power plant coming to Wales - November 21, 2007.
Forbes: UK govt gives go ahead for construction of world's largest biomass plant - November 21, 2007.
South Wales Evening Post: Green Light for £400m power plant - November 21, 2007.
The EU kicks off a major research effort to study advanced pre-combustion carbon capture technologies for coal and gas-fired power plants. The DECARBit project [*.pdf] will be coordinated by Norway's SINTEF Energy Research, will last for four years, and has a total budget of €15 million (NOK 120 million), of which €5.6 milion (NOK 45 million) will go to research at SINTEF and the Norwegian University of Science and Technology in Trondheim (NTNU). The project involves 14 partners from eight different countries.
Biopact tracks the latest developments in carbon capture technologies, because they can be applied to biomass to yield negative emissions electricity and fuels. The economics and carbon reduction potential of pre-combustion capture (and consequent storage of CO2) has been studied for biomass by different researchers. In one study, for the Interntional Energy Agency's Greenhouse Gas R&D Programme, scientists found the technique, when coupled to biomass (eucalyptus/acacia) used in Integrated Gasification Combined Cycle (IGCC) plants, could result in electricity with a negative carbon balance of -1030 grams of CO2 per kWh. In short, each time you were to use this electricity, you would be taking CO2 out of the atmosphere. Such negative emissions systems, also called 'bio-energy with carbon storage' (BECS) are the only concept that can achieve this. All other renewables and energy sources (nuclear, solar, wind, etc) are all 'carbon-neutral' at best, that is, they do not add new emissions (0 emissions per kWh). BECS on the contrary goes much further and effectively takes emissions from the past out of the atmosphere.
Ultimately, the commercial feasibility of BECS depends on fossil fuel and carbon prices, and on the emergence of a global carbon market. Obviously, the higher the market price for CO2 emissions and fossil fuels, the bigger a winner bio-based negative emissions energy becomes. Many different projections have been made but they date from before the recent surge in fossil energy prices.
The EU's DECARBit project will deal with next-generation technology for CO2 capture in IGCC plants and will contribute to making future technology very much cheaper than the technology that is available for use today. The most mature technology for CO2 capture at coal- and gas-fired power stations utilises scrubbing of the flue-gases by means of chemicals to separate CO2 - socalled 'post-combustion' capture.
DECARBit deals with the challenges that arise from techniques to remove the carbon in carbonaceous fuels before they are sent to the power plant. If this 'decarbonisation' fuel route is chosen, the coal, natural gas or biomass will go to the processing plant, where it will be gasified into syngas, a hydrogen and carbon monoxide rich gas. The carbon monoxide is traditionally turned into CO2 via the water gas shift reaction (WGS), so that it can be captured and stored. The hydrogen rich fuel is then sent to the power plant and used as the fuel to generate electricity. The EU project will allow the SINTEF and NTNU scientists to contribute to new technologies that will cut the costs of separating out these components of the gas mixture (schematic, click to enlarge).
In a first phase of the project, system integration and a techno-economic analysis will be carried out, alongside an assessment of operational requirements.
The second phase consists of developing advanced pre-combustion technologies on the basis of membranes, CO2 sorbents and novel sorbent systems.
Thirdly, advanced oxygen separation technologies will be created, further developing oxygen transfer membranes, hybrid membranes and advanced sorbent based technologies.
The final phase of the project consists of testing the technology in a pilot plant.
The news about the EU contract for SINTEF arrived just a week after a proposal for next year's Norwegian national budget was presented to the country's parliament. The proposal made it clear that the Norwegian government intends to freeze funding for research on CO2 handling at NOK 48.5 million. DECARBit's funds are three times as large - a major boost to SINTEF.
In the course of the next six years, the EU will invest no less than €390 million (about NOK 3 billion) in research and development on CO2 capture and storage – so called CCS technologies.
DECARBit is the latest in a long series of EU projects that SINTEF and NTNU have joined during the past few years in the field of CO2 handling. SINTEF and NTNU lead five of these projects.
The Norwegian success within the EU research in this topic can partly be attributed to a "national team" spirit. The co-operation with StatoilHydro - which has developed large experience with carbon-capture from natural gas - is important, as is the CCS track-record of Norway - most recently added to this is the Snøhvit CCS operation.
Biopact wishes to add in this context that there is a much simpler way of capturing carbon dioxide from biomass, without the need to make the detour via gasification and complex high-temperature gas shifting and separation. The concept consists of capturing CO2 from biogas obtained from anaerobic digestion of biomass. Contrary to the gasification route, which involves high temperatures and the need for complex shift reactions and robust gas separation technologies that withstand the high temperatures (e.g. new membranes), CO2 capture from biogas is basically a 'cold process' and can rely on a range of existing gas separation technologies (add that new, highly efficient membranes have meanwhile been developed that would allow such a cold process - more here).
So why hasn't this 'cold' separation technique been used to capture CO2 from raw natural gas? The answer is simple: natural gas only contains small amounts of CO2, making pre-combustion capture from the raw gas futile. Biogas on the contrary contains up to 40% of CO2. The rest is methane and trace gases. Because of this large amount of CO2, cold carbon capture would be feasible, provided a large stream of biomass is available that can easily be digested in ultra-large facilities. Mind you, this concept is new and has not received much research yet.
Alternatively, carbon can be captured from ethanol production, which yields a pure stream of CO2 during the fermentation stage. But this CO2 makes up only a fraction of the carbon contained in the initial biomass feedstock. This means one would not obtain a carbon-negative fuel, but only an ethanol with a lower carbon footprint. And here again, coupling CCS to ethanol production would require ultra-large production facilities to legitimize the investment in carbon capture technologies for a relatively small stream of CO2.
Finally, and this concept has received much more attention, biomass and coal can be co-fed as feedstocks to produce synthetic liquid fuels with a zero-emissions footprint. Depending on the ratio of biomass versus coal, such 'coal+biomass-to-liquids' fuels coupled to CCS could once again become carbon-negative. On these ultra-clean, low carbon fuels, see a recent study conducted by the USAF and NET.
In the future, carbon-negative hydrogen from decarbonized biomass will be used in the hydrogen economy. Biomass is gasified, the CO2 captured and stored, and hydrogen with a negative emissions footprint is obtained that can be used in fuel cells and power plants.
European Commission, DG Research: DECARBit project.
SINTEF: SINTEF to lead major EU project on the CO2 technology of the future - November 19, 2007.
Seattle-based bioscience company Targeted Growth has entered into a joint venture agreement with Houston biodiesel maker Green Earth Fuels to produce and market 100 million gallons (378.5 million liters) of biodiesel by 2010 from purpose-bred camelina. The oilseed crop belongs to the Brassicaceae family, in which the more commonly used biodiesel crop rapeseed can be found. The new company is called Sustainable Oils, Inc. and launches the single largest U.S. contract for the unique biodiesel-specific feedstock. Nearly all of the initial camelina production is expected to be grown in Montana.
Camelina sativa (L.) Crantz., traditionally yields about 1,100 to 1,200 kg of seeds per hectare, with an oil content that ranges from 35 to 37.5%. Whereas other Brassicas like rapseed have been improved significantly through plant breeding (e.g. canola) and improved agronomic practices, camelina has largely not had these benefits (more here).
This has now changed. With knowledge of a growth-controlling gene discovered at the Fred Hutchinson Cancer Research Center, Targeted Growth says it has bred a stronger, taller variety of camelina that yields 20 percent more oil than the standard variety and can be grown on marginal lands with little water or fertilizer. The crop can be harvested with traditional equipment.
Targeted Growth has spent the past three years applying its suite of yield and trait technologies to camelina to create the first Elite Camelina Seed. Specifically, it has used non-transgenic molecular assisted breeding programs to create a crop that is well suited to Montana's climate and soil and that produces high quality biodiesel.
This is really, really big. With gas and energy prices on the rise, climate change breathing down our neck, and instability in the Middle East, America has to do something different. What's most exciting about this new project is that Montana is going to be part of the energy solution. The fertile fields of Big Sky Country will be on the cutting edge of a bright energy future for America. And not only are we developing new cleaner energy sources, we are creating jobs and boosting Montana's economy too. I take my hat off to everyone who came together on this project and I have great faith that it's going to surpass all expectations.
Headquartered in Houston, Texas, Green Earth Fuels is a U.S. leader in the production and distribution of environmentally sound biodiesel with a vertically integrated business model representing end-to-end fuel production. Green Earth Fuels operates production and distribution sites that are independently located within existing petrochemical infrastructures in key U.S. coastal locations, improving industry integration and providing dedicated access to a nationwide production network alongside well-situated distribution channels. The company develops and invests in the production of new feedstock crops and adheres to best practices farming of current crops to promote feedstock sustainability, maximize processing benefits, and minimize environmental impacts.
Targeted Growth uses agricultural bioscience to enable the long term success of renewable fuels such as biodiesel and ethanol. This includes technology that improves the traits of crops themselves (yield increases, drought resistance, fertilizer requirements, etc.) and the ultimate performance of those crops once converted into biofuels (efficiency of refining, fuel performance characteristics). In addition, the company also develops, grows and markets biofuel specific crops (such as camelina) that are optimized and continually improved for use specifically as a feedstock for biofuels. The company has strategic partnerships with leading researchers and agribusinesses around the world. Targeted Growth is based in Seattle, Wash. with labs in Seattle, Saskatchewan, Ottawa and New Brunswick.
to Produce Camelina-based Biodiesel [*.pdf] - November 20, 2007.
D.H. Putnam, J.T. Budin, L.A. Field, and W.M. Breene, "Camelina: A Promising Low-Input Oilseed", Handbook of Energy Crops.
The United Nations Environment Programme (UNEP) has launched two new renewable energy initiatives in the eastern and southern African agricultural sector aimed at strengthening access to energy in rural areas, greening power generation and alleviating poverty. The tea and sugar industries, which employ millions of farmers in the region, will become recipients of small hydropower and bioenergy projects, resulting in more than 70MW of decentralized sustainable energy. The UNEP recently published its new state of the world environment report - the Global Environment Outlook-4 - in which it stresses the urgent need to take sustainable development seriously and why clean energy lies at its core.
The two pioneering initiatives - Cogeneration for Africa and Small Hydro for Greening the Tea Industry - are being spearheaded by UNEP with the African Development Bank (ADB) as co-implementer and supported by the Global Environment Facility (GEF). Co-financiers are the Renewable Energy and Energy Efficiency Partnership (REEEP) and the EU's ProInvest. The projects, worth around $100 million in total, are being co-executed by the East African Tea Trade Association (EATTA) and the Energy, Environment and Development Network for Africa (AFREPREN/FWD).
The East African Tea Trade Association will begin its four year initiative to establish six small hydropower demonstration projects in at least four EATTA member countries generating a total of 10MW. The industry will use resources available at tea plantations to power the industry, rather than utilize expensive electrical resources. The demonstration is expected to stimulate 82MW of small hydro capacity in the region over the coming years. The project has been endorsed by eight countries in the region, namely: Kenya, Uganda, Malawi, Zambia, Burundi, Mozambique, Rwanda and Tanzania.
Meanwhile the sugar industry is preparing to produce its own electricity and heat in a series of cogeneration projects modeled on the success of biomass cogeneration in Mauritius, where up to 40 per cent of the country's electricity needs are met by waste by-products from the sugar industry. The sugar industry's initiative will last six years and is expected to result in the development of 60MW of biomass cogeneration projects in its initial pilot phase, and eventually set the stage for the installation of over 200MW of cogeneration capacity across the region, out of a total current potential of 730MW (table, click to enlarge). The project thus seeks to significantly scale up the use of biofuels in efficient cogeneration systems in seven Eastern and Southern African countries, namely: Kenya, Ethiopia, Malawi, Sudan, Uganda, Tanzania and Swaziland.
Monique Barbut, CEO and Chairperson of the Global Environment Facility added that this latest partnership between GEF and UNEP is a concrete example of how under the right government policy framework, sustainable development can work, and does work.
Both regional initiatives were formally presented by Kenyan President, H.E. Mwai Kibaki, who stressed the need for rural electrification and alternatives to costly fossil fuels.
The importance of harnessing alternative forms of energy generation is highlighted in the latest assessments of the Intergovernmental Panel on Climate Change (IPCC) and UNEP's new state of the world environment report - the recently launched Global Environment Outlook-4.
The initiatives are co-financed by the Renewable Energy and Energy Efficiency Partnership (REEEP) and ProInvest. REEEP funding for the project was provided by the Government of Ireland which targets sustainable energy projects in Sub-Saharan Africa.
The contributions from the Irish Government enable REEEP to support projects in eastern and southern Africa, including Ethiopia, Lesotho, Mozambique, Tanzania, Uganda and Zambia.
The launch of the projects was followed by a two-day REEEP sponsored training workshop on "Financing Cogeneration and Small-Hydro Projects in the Sugar and Tea Industry in East and Southern Africa". The workshop provided industry representatives with a clear understanding of the barriers to financing renewable energy and energy efficiency in the tea and sugar industries; provided a comprehensive grasp of the risks associated with lending to sugar and tea industries for energy projects and how to mitigate these risks; and increased awareness among financial institutions and investors of the opportunities for financing REEEP in agro-industries and options for managing risks.
The Global Environment Facility is an international financial mechanism with 178 member countries that addresses global environmental issues while supporting national sustainable development initiatives. GEF grants support projects in developing countries related to biodiversity, climate change, international waters, land degradation, the ozone layer and persistent organic pollutants. Since its inception in 1991, GEF has achieved a strong track record of support to developing countries and countries with economies in transition, providing $6.2 billion in grants and leveraging $20 billion in co-financing for over 1,800 projects in over 150 countries. Through its Small Grants Programme (SGP), GEF has also made more than 7,000 small grants, up to $50,000 each, directly to nongovernmental organizations and community organizations.
The United Nations Environment Program is involved in a series of projects to address environmental consequences of energy production and use, and assists decision-makers in governments and the private sector to make better, more informed energy choices which fully integrate environmental and social costs. GEO-4, which was released on 25 October, is the latest in a series of flagship UNEP reports assessing the current state of the global atmosphere, land, water and biodiversity. It is the most comprehensive UN report on the environment, prepared by about 390 experts and reviewed by more than 1,000 others across the world over a five-year period.
The Renewable Energy and Energy Efficiency Partnership (REEEP) is an active, global public-private partnership that structures policy and regulatory initiatives for clean energy, and facilitates financing for energy projects. Backed by more than 200 national governments, businesses, development banks and NGOs, REEEP is uniquely placed to contribute to international, national and regional policy dialogues. Our aim is to accelerate the integration of renewables into the energy mix and to advocate energy efficiency as a path to improved energy security and reduced carbon emissions, ensuring socio-economic benefits.
Picture: Sugar cane in Kenya being transported to a factory. 'Cogen for Africa' aims to get biomass-based CHP on the road for east and southern Africa. Credit: UNEP/Cogen for Africa.
UNEP: COGEN for Africa - project overview, with a wealth of information on bioenergy and rural development.
UNEP: Greening the Tea Industry in East Africa - project overview.
UNEP: Global Environment Outlook: environment for development (GEO-4) - October 2007.
UNEP-GEF, AfDB, REEEP, EATTA and AFREPREN/FWD: Joint Small Hydro and Cogeneration Projects Launch and Capacity Building Workshop - November 8, 2007.


text:
eloc-committee@googlegroups.com
Friends Information
Rehearsal Venues
History of ELOC
Company Rules
About Crazy For You
Crazy For You Resources
Crazy For You Cast
Our Forthcoming Productions
Would you like to be one of our Friends? This is open to anyone who would like to support the Company but not perform in any productions. For an annual fee of £20 you are entitled to £1 off each ticket purchased through the ELOC Box Office.
You will also receive a quarterly copy of our newsletter 'TABS', which keeps you up to date with what's going on in the Company and details of all our upcoming social events. You also get an invitation to the 'Friends' Christmas Party', where you are freely wined, dined and entertained as our valued guests!
If you are happy to be our Friend kindly send a cheque for £20, made payable to ELOC, to the Secretary to the Friends of ELOC, address as below, together with your details (address, phone number and e-mail address). You will also then be able to register as a member on this website, enabling you to see and use the members-only parts of the site. If you have any questions, you can e-mail Charlie direct from this site (see Contact Us).
© 2020 All Rights Reserved - Epsom Light Opera Company Details of our Privacy Notice can be found here
We are using cookies to provide statistics that help us give you the best experience of our site. You can switch them off if you prefer. However, by continuing to use the site without changing settings, you are agreeing to our use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

redpajama_set_name: RedPajamaCommonCrawl


Earlier today you saw Rod's unboxing and hardware tour of the new Microsoft Band 2 that became available today from Microsoft.
He will be providing a truly fitness geek perspective of the new device as he begins using it over the next several days.
For myself, I will be taking the new version of the Band on the road with me as I head out to the Microsoft Campus for the next week. The annual Microsoft Most Valuable Professional Summit begins on Monday and I will be arriving in the Seattle area this weekend.
I expect to be putting a lot of steps on the new device as I go between hotels, meetings and other events throughout the week.
You can expect my own perspective on the new wearable from Microsoft in about a week or so.
Until then I wanted to share the new setup in the Microsoft Health app as I paired v2 of the Band with my LG G4 Android smartphone.
I have also included a few of my own unboxing shots as I am just impressed with the packaging that Band arrived in and what will be experienced on retail shelves.
Enjoy and let us know if you have received your new Band and what your initial impressions are of the device.


Imagers will love DayStar Quark to T adapter, for mounting T thread cameras directly and rigidly to the Quark. Quark and camera not included.
Compatible with the T thread Interference Eliminator, which is recommended for removing the banding from Newton's rings.
Net weight 0.06 lb, shipping weight 0.5 lb.


Continuing on with our reviews of all the Valentine's Month at Disneyland treats, we went over to Red Rose Taverne to try the Cherry Mousse.
This dessert was supposed to be comprised of dark chocolate ganache and chocolate crunch, red velvet spray with gold dust, and mini heart sprinkles, but we didn't find any chocolate crunch in ours.
There was a thin layer of chocolate cake topped with a dark chocolate ganache covered in cherry mousse. The cherry mouse was actually our least favorite part of this dessert. It tasted extremely artificial and the consistency of the mousse was weird. It was entirely too airy and lacked any richness or creaminess. The cake on the other hand, was very moist and the ganache was rich and flavorful. Unfortunately, these components were overpowered by the sugariness and artificial flavor of the cherry mousse. This dessert would have been better balanced if it had a lot more cake and ganache and a lot less cherry mousse.
While it wasn't awful, it definitely wasn't great. There are so many better options currently available that I have a hard time recommending this one.


Sealink Marine specialises in all marine services including new and second hand boat sales, sales of new and used marine engines, sales of new and used parts, engine servicing and rebuilds, fit outs and engine repowers and all other marine services. Sealink also exports new and used parts and marine engines all over the world.
Simon Carter, Sealink Marine's founder, started his career in the marine industry at the original Patterson Lakes marina in Victoria, back in 1975. Today, Simon leads the team as a certified Mercury and Mercruiser technician and is also a factory trained Yanmar technician. He has been servicing and selling Volvo engines for over 35 years and is truly one of Australia's most qualified and experienced marine technicians. Our staff are also factory trained with extensive experience and are constantly upgrading their skills to provide service and repower expertise. We have recently been appointed Victoria's sole agents for John Deere Marine and industrial engines. We are Mercruiser/Cummins and Yanmar authorised dealers, and MTU Diesel agents.
Sealink Marine operates with a network of professional marine suppliers throughout Australia. With decades of experience and considered a leader within the marine industry, we are professionals you can really trust.


text:
Lynch Gives Thanks After Win
Notebook: Thomas gets one snap at QB; Run game can't get going in loss to Seahawks
Seahawks running back Marshawn Lynch plunges in for the frist of two touchdown runs against the Cardinals Sunday.
It was no surprise to see the spotlight shine on Marshawn Lynch several times during Sunday Night Football. It was equally as expected to watch him deflect the attention after it was over.
All eyes were on the Seahawks' star running back in the first quarter as he stood on the sideline, unable to play because of reported stomach issues. He got his first carry in the second quarter and quickly became a major factor in the result, running 10 times for 113
yards and two touchdowns, including a 79-yarder to put the game away in the fourth.
After getting hit with a $100,000 fine earlier this season for not speaking with the media, Lynch made himself available in the visitor's locker room following the 35-6 win, but in his own unique way.
Lynch was asked eight questions about the game and answered each with a variation of "thanks for asking." The most in-depth reply he gave centered around his stomach issues.
"I appreciate you asking about my stomach," Lynch said. "Thank you."
The always loquacious Richard Sherman helped fill the gap. He talked about Lynch's long scoring run, comparing it to the memorable touchdown rumble against the Saints in the playoffs in the 2010 season.
"What more can you say about that run?" Sherman said. "Beastmode Two -- that might be Beastmode One. The other one might be Two now."
LOGAN THOMAS' APPEARANCE LIMITED TO ONE SNAP
It's unknown how many plays were created for rookie quarterback Logan Thomas this week, but only one saw the light of day. He
entered the game in the second quarter on first-and-10 from the Arizona 8. It was a high-risk, high-reward call, as Thomas dropped back into the end zone and attempted to unleash a long bomb down the left sideline to John Brown.
Thomas was hit as he threw it and the ball never had a chance to be completed.
"Just didn't have quite enough time," Thomas said. "Smokey ran a great route and was open. I would've had to give him a good ball, but we had a shot at it."
Coach Bruce Arians said postgame he "never" considered making a permanent switch from Ryan Lindley to Thomas, although the backup said he was prepared to re-enter later for more of his plays if needed.
"I wasn't sure (what was going to happen)," Thomas said. "I just knew what I had (practiced) and if he called my name I was going to be ready to go."
LITTLE HELP FROM RUNNING GAME
The Cardinals hoped to give Lindley some support with a solid rushing attack, but it never materialized. Stepfan Taylor finished with 11 carries for 19 yards and the team had 15 carries for 29 yards total because it trailed most of the contest.
"We probably should have run the ball more," Arians said.
Running back Kerwynn Williams, who had 34 carries for 175 yards in the past two games since getting elevated from the practice squad, had two carries for four yards. While Williams was listed on the injury report this week with a knee issue, Arians said health wasn't a factor. Taylor and Marion Grice saw the majority of the snaps because they are better pass blockers, Arians said.
SEAHAWKS' ISSUES LET CARDINALS HANG AROUND
While the Cardinals could never get going offensively, it was still a one-score game heading into the fourth quarter because Seattle had several self-inflicted wounds.
Kicker Steven Hauschka missed three field goals in the first three quarters after entering the game 29-of-32 on the season. He sent the first two kicks wide right and the final one wide left.
The Seahawks also had 11 penalties for 92 yards in the first half. On consecutive plays in the second quarter, defensive end Michael Bennett was whistled for lining up offsides, which helped lead to a Cardinals field goal.
"One of those times, I was offsides," Bennett said. "The other time, I wasn't offsides. They've just never seen nobody get off the ball like that."
WATFORD, GLENN CARSON SEE TIME
Guard Earl Watford played in his first NFL game on offense, filling in for an injured Ted Larsen at left guard for a handful of snaps in the second half. Watford was the backup guard because Jonathan Cooper missed the game with a wrist injury. Larsen eventually returned to the game.
Linebacker Glenn Carson has been inactive for much of the season but saw defensive playing time in some run-stopping packages against the Seahawks. He had one tackle.


text:
[![Github Actions](https://github.com/commitizen-tools/commitizen/workflows/Python%20package/badge.svg?style=flat-square)](https://github.com/commitizen-tools/commitizen/actions)
[![Conventional Commits](https://img.shields.io/badge/Conventional%20Commits-1.0.0-yellow.svg?style=flat-square)](https://conventionalcommits.org)
[![PyPI Package latest release](https://img.shields.io/pypi/v/commitizen.svg?style=flat-square)](https://pypi.org/project/commitizen/)
[![PyPI Package download count (per month)](https://img.shields.io/pypi/dm/commitizen?style=flat-square)](https://pypi.org/project/commitizen/)
[![Supported versions](https://img.shields.io/pypi/pyversions/commitizen.svg?style=flat-square)](https://pypi.org/project/commitizen/)
[![homebrew](https://img.shields.io/homebrew/v/commitizen?color=teal&style=flat-square)](https://formulae.brew.sh/formula/commitizen)
[![Codecov](https://img.shields.io/codecov/c/github/commitizen-tools/commitizen.svg?style=flat-square)](https://codecov.io/gh/commitizen-tools/commitizen)
[![pre-commit](https://img.shields.io/badge/pre--commit-enabled-brightgreen?style=flat-square&logo=pre-commit&logoColor=white)](https://github.com/pre-commit/pre-commit)

![Using commitizen cli](images/demo.gif)

---

**Documentation:** [https://commitizen-tools.github.io/commitizen/](https://commitizen-tools.github.io/commitizen/)

---

## About

Commitizen is a tool designed for teams.

Its main purpose is to define a standard way of committing rules
and communicating it (using the cli provided by commitizen).

The reasoning behind it is that it is easier to read, and enforces writing
descriptive commits.

Besides that, having a convention on your commits makes it possible to
parse them and use them for something else, like generating automatically
the version or a changelog.

### Commitizen features

- Command-line utility to create commits with your rules. Defaults: [Conventional commits][conventional_commits]
- Display information about your commit rules (commands: schema, example, info)
- Bump version automatically using [semantic versioning][semver] based on the commits. [Read More](./bump.md)
- Generate a changelog using [Keep a changelog][keepchangelog]

## Requirements

Python 3.6+

[Git][gitscm] `1.8.5.2`+

## Installation

Global installation

```bash
sudo pip3 install -U Commitizen
```

### Python project

You can add it to your local project using one of these:

```bash
pip install -U commitizen
```

```bash
poetry add commitizen --dev
```

### macOS

On macOS, it can also be installed via [homebrew](https://formulae.brew.sh/formula/commitizen):

```bash
brew install commitizen
```

## Usage

### Committing

Run in your terminal

```bash
cz commit
```

or the shortcut

```bash
cz c
```

#### Sign off the commit

Run in the terminal

```bash
cz commit --signoff
```

or the shortcut

```bash
cz commit -s
```

### Integrating with Pre-commit
Commitizen can lint your commit message for you with `cz check`.
You can integrate this in your [pre-commit](https://pre-commit.com/) config with:

```yaml
---
repos:
  - repo: https://github.com/commitizen-tools/commitizen
    rev: master
    hooks:
      - id: commitizen
        stages: [commit-msg]
```

After the configuration is added, you'll need to run

```sh
pre-commit install --hook-type commit-msg
```

Read more about the `check` command [here](check.md).

### Help

```bash
$ cz --help
usage: cz [-h] [--debug] [-n NAME] [--version]
          {init,commit,c,ls,example,info,schema,bump,changelog,ch,check,version}
          ...

Commitizen is a cli tool to generate conventional commits.
For more information about the topic go to https://conventionalcommits.org/

optional arguments:
  -h, --help            show this help message and exit
  --debug               use debug mode
  -n NAME, --name NAME  use the given commitizen (default:
                        cz_conventional_commits)
  --version             get the version of the installed commitizen

commands:
  {init,commit,c,ls,example,info,schema,bump,changelog,ch,check,version}
    init                init commitizen configuration
    commit (c)          create new commit
    ls                  show available commitizens
    example             show commit example
    info                show information about the cz
    schema              show commit schema
    bump                bump semantic version based on the git log
    changelog (ch)      generate changelog (note that it will overwrite
                        existing file)
    check               validates that a commit message matches the commitizen
                        schema
    version             get the version of the installed commitizen or the
                        current project (default: installed commitizen)
```

## Setting up bash completion

When using bash as your shell (limited support for zsh, fish, and tcsh is available), Commitizen can use [argcomplete](https://kislyuk.github.io/argcomplete/) for auto-completion. For this argcomplete needs to be enabled.

argcomplete is installed when you install Commitizen since it's a dependency.

If Commitizen is installed globally, global activation can be executed:

```bash
sudo activate-global-python-argcomplete
```

For permanent (but not global) Commitizen activation, use:

```bash
register-python-argcomplete cz >> ~/.bashrc
```

For one-time activation of argcomplete for Commitizen only, use:

```bash
eval "$(register-python-argcomplete cz)"
```

For further information on activation, please visit the [argcomplete website](https://kislyuk.github.io/argcomplete/).

[conventional_commits]: https://www.conventionalcommits.org
[semver]: https://semver.org/
[keepchangelog]: https://keepachangelog.com/
[gitscm]: https://git-scm.com/downloads

redpajama_set_name: RedPajamaGithub


Looking for the perfect InkJet Coder? Enjoy a fully portable printer that simplifies offline package marking and products marking. With easy to read characters, consecutive numbering, time and date and graphics, the EBS 260 Handjet is the perfect InkJet Coding Printer.
The EBS 260 has everything you need for precise, fully mobile number, time, and date stamp imprinting. Store and Imprint multi-line messages for on-demand, Large Character InkJet printing. Take your day to day business activities to the next level with an EBS 260 Handjet today.
A Mobile Electronic Number Stamp for Product Marking or Large Parts Marking applications.
All you need for precise, Fully mobile, Number, Time, Date Stamp imprinting.
Simply "Press" the Black Button to activate printing for non-contact printing on flat or uneven surfaces...THEN, start rolling the EBS-260 , by making contact with the stabilizer wheels onto the surface being imprinted.
A total of (10) Imprint Layouts can be stored and recalled in the unit (1,500 character(s) per each of the (10) imprint layouts).
Print on any absorbent surface.
Print on any non-absorbent surface.
Reliable Print Performance - suitable for harsh and dirty environments.
**Ink Colors are NON-Interchangeable. Only one Color Ink can be utilized in a Handjet Printer.
Automatically advances the Time, Date and Numbers internally.
Variable Print Data can be configured; Counters, Expiration Dates, etc.
Complete HandJet EBS-260 Inkjet Coding Printer Kit includes; (1) EBS-260 HandJet Printer with carrying case, (1) Configuration Software, (1) USB Bluetooth Module, (1) USB Cable for module, (1) Black Acetone Ink Jet Cartridge, (1) Power Pack and cable, (1) Spray Bottle, (1) User Manual.
Applications: A Totally mobile Solution for Time Date Numbering, and Graphics...uses such as; Parts Marking, Package Marking and validating in product manufacturing processes, and packages in transit, quality control validation, laboratory timing and checking, production controls, large product marking and where part marking needs to be performed in dusty and dirty environments.
**Radio Frequency usually operates up to only 150 Feet.
Transfer of imprint layout(s) and backup of configuration.
**Optional Stabilizers may be required to acheive optimal Imprinting on Curved Surfaces!
Utilize the EBS-260 HandJet for InkJet Coding on Concrete Pipe Product Marking, PVC Pipe or Tubes and Steel Building Materials or packaging. Textiles and Upholstery products can now be marked legiably.
Utilize the EBS-260 HandJet for InkJet Coding in the Timber Industry on Wooden Tree Trunks, or to code Wooden Shipping Crates, imprints for traceability in warehousing and when the product marking is to be imprinted on curved containers such as paperboard cores and mammouth sized items anywhere.
Watch this video to see the HandJet EBS260 InkJet Coding Printer in action.
Ink Cartridges: Water based, Ethanol, Acetone in various colors.
Print Timing Speed: Synchronized with rotational speed of lower stabilizer, or at intervals by an internal generator.
Humidity: Up to 95% non-condensing: printer will operate in rain, (surface being imprinted must be dry).
Storage Temperature, for water based inks: 34F degrees to 113F degrees.
Storage Temperature, for ethanol or acetone inks: 14F degrees to 113F degrees.


It would be difficult to have escaped hearing the ongoing discussion and debate on the lobbying for a cut in the corporation tax rate for Northern Ireland, with some arguing for a rate of 12.5% similar to that enjoyed by the Republic of Ireland (RoI). It has been argued that the proposal to reduce the rate of corporation tax is a central plank of a strategy now required to rebalance the Northern Ireland economy, and to address the significant growth required in the private sector of our economy. Others though have taken the view that additional tax incentives, for example, for investment in innovation, would be a more attractive proposition in seeking to stimulate economic growth in the Province. It has been recognised that tax incentives have a key part to play in encouraging innovation. In the RoI tax incentives have historically been used to both attract foreign direct investment, and to encourage home-grown innovation. Tax incentives The UK Government has recognised that encouraging innovation is a vital component in a strategy for improving the UK's productivity, performance and competitiveness. The UK R&D Tax Relief Regime was introduced in April 2000 for Small & Medium Sized Enterprises (SMEs), and two years later extended to include Large Companies. The regime exists to incentivise and motivate companies to invest in innovation. Northern Ireland as a region stands to benefit greatly from such an incentive, where the rate of R&D tax relief for SMEs is an extremely generous 17.5%, which translates to a 21% tax saving, assuming a rate of corporation tax of 28% applies. The mechanics of operating the RoI R&D Tax Credit Scheme are slightly different in that a company can claim a tax credit of 25% of incremental qualifying R&D expenditure in any year, which is then used to reduce the corporation tax payments for the company in the year. Unlike the UK system, where the company can claim the relief on the whole of the qualifying R&D expenditure in any year, the RoI system only permits relief to be claimed on the "incremental" spend in a particular year over and above the base year spend – taken as the spend in the 2003 year for all accounting periods. Even with such a generous level of relief under the UK system, the level of take-up in Northern Ireland was extremely disappointing in the early years. A large number of companies failed to recognise their entitlement to the relief believing it only to apply to the "test tube and white coat" type of research, and not to other areas of R&D. Encouragingly there has been a dramatic increase in the level of reported spend on R&D in our local economy. The Department of Enterprise, Trade and Investment reported in December that total business R&D expenditure in 2009 was £323.7m, up £139.8m (76.0%) on the previous year – the largest annual increase since the annual R&D survey began in 2001. The challenge will be for those companies investing in R&D to ensure they are fully availing of all the tax incentives available. Innovation reports The RoI has also experienced significant rises in the level of R&D spend reported, predominantly fuelled by a number of large Foreign Direct Investment companies choosing to locate there, including some of the world's leading research-intensive multinationals. Total R&D spending as reported in the RoI almost trebled to €2.6bn in 2008, equivalent to 1.66% of the Gross National Product (GNP), with expenditure by businesses accounting for close to €1.68bn of this total. Even with our encouraging reported increase in the level of R&D expenditure by business in Northern Ireland, we still have some way to go to compare to that experienced south of the border. To encourage even greater focus on Innovation in the RoI, the RoI Government commissioned an Innovation Taskforce. One of its key recommendations was in relation to improving the existing R&D tax credit. Interestingly in the UK, David Cameron, as Leader of the Conservatives Party, commissioned Lord James Dyson in October 2009 to carry out a review to "help the Conservatives reawaken the UK's innate inventiveness and creativity". The Report, published in March 2010, contained many recommendations – which at this stage have yet to be implemented. David Cameron commented that "we will consider the implementation of the Dyson Review to make the UK the leading hi-tech exporter in Europe, and refocus the research and development tax credit on hi-tech companies, small firms and start-ups." There is a clear recognition in both jurisdictions that tax incentives have a significant part to play in encouraging further investment in innovation, and in serving to stimulate future economic growth. The successful exploitation of new and existing ideas is the means by which regional economies can differentiate and exploit their unique skills and capabilities in order to compete in the global economy.


Showing results by author "K.C. Dunford"
An eerie voice interrupts Christian's ordinary life, haunting him at every turn. In a matter of days, the menacing voices and shadowy shapes become the least of his troubles. Christian decides he must face his foes or live forever in fear. In doing so, a mysterious force drags him into a strange and unfamiliar land where the unnatural terrors are somehow perfectly catered to torment him. Christian is soon discovered by the inhabitants of this new realm. He may think himself a victim of circumstance, but he soon discovers he has been chosen to determine the fate of an ancient people.


text:
Tag Archives: East of England
Dementia Case-Finding in Hospitals: Qualitative Research Into Disparate Perceptions of Primary and Secondary Care Staff in England (BMJ Open)
Summary Hospitals in England have been conducting case-finding of people with dementia among older people, who were admitted on an unplanned basis, since 2012/13; although the methods to be used were undefined. A recent article investigates the views of staff … Continue reading →
Posted in Acute Hospitals, Commissioning, Community Care, Delirium, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest	| Tagged Access to Diagnostics and Secondary Care Advice, Access to Secondary Care, Acute Hospital Care, Acute Hospitals, Ageing and Dementia, Ageing and Society, Ageing Population, Barriers to Older People Accessing Help and Support, Barriers to Support, Bedfordshire, BMJ Open, BMJ Publishing Group Ltd, Bureaucracy, Bureaucracy and Burnout, Cambridge Institute of Public Health: University of Cambridge, Cambridgeshire, Case Finding, Case Finding for Patients with Dementia, Centre for Research in Public Health and Community Care: University of Hertfordshire, Dementia and Delirium, Dementia Care in Acute Settings, Dementia Care in General Hospitals, Dementia Care in the Acute Hospital, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Case-Finding in Acute Hospitals in England, Dementia Diagnosis, Dementia Diagnosis Rates, Dementia Diagnosis Rates in England, Dementia in General Hospital Inpatients, Dementia-Friendly Hospitals, Dementia-Related Misdiagnosis, Diagnosis and Assessment, Diversion of Resources, Early Diagnosis, Early Screening, East of England, Essex, Faculty of Medicine and Health Sciences: University of East Anglia, False Positives, Family Doctors, Family Support, General Hospital Care, General Hospitals, GPs, Hertfordshire, Impact of the Quality of Dementia Care on Interface Between Primary and Secondary Care, Misdiagnosis, Mislabelling (Risk), Norfolk and Suffolk, Norwich Medical School: University of East Anglia, Post-Diagnosis Support, Post-Diagnostic Dementia Care And Support, Post-Diagnostic Support for People with Dementia, Potential Harms of Diagnosis, Primary / Secondary Care Interface, Primary and Secondary Care, Primary Care, Primary Care (GPs), Primary Care Factors in Unscheduled Secondary Care, Qualitative Research, Quality and Outcomes Framework (QOF) Dementia Registers, Quality Outcomes Framework (QOF), Quality Outcomes Framework (QOF): Recorded Dementia Diagnoses, Recorded Dementia Diagnoses, Referral and Assessment, School of Clinical Medicine: University of Cambridge, Screening, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening for Dementia, Screening Programmes, Secondary Care, Support for People Living with Dementia and Their Carers, Target Culture, Target-Driven Behaviour, Target-Driven Priorities, Timely Diagnosis, UK National Screening Committee, UK National Screening Committee (UK NSC), University of Cambridge, University of East Anglia, University of Hertfordshire	| Leave a comment
Local Variations in Neurology Outpatient Services in England (PHE)
Summary The Public Health England (PHE) Neurology Intelligence Network (NIN) has published a statistical briefing concerning neurological outpatient activity in England. This concentrates particularly on local CCG services. Quality improvements may be achievable by examining variations in local service provision, … Continue reading →
Posted in Commissioning, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Local Interest, Management of Condition, National, NHS, Public Health England, Quick Insights, Royal College of Physicians, Standards, Statistics, UK, Universal Interest	| Tagged Airedale Wharfedale and Craven CCG, Ashford CCG, Association of British Neurologists, Aylesbury Vale CCG, Barking & Dagenham CCG, Barnet CCG, Barnsley CCG, Basildon and Brentwood CCG, Bassetlaw CCG, Bath and North East Somerset CCG, Bedfordshire CCG, Bexley CCG, Birmingham CrossCity CCG, Birmingham South and Central CCG, Blackburn with Darwen CCG, Blackpool CCG, Bolton CCG, Bracknell and Ascot CCG, Bradford City CCG, Bradford Districts CCG, Brent CCG, Brighton & Hove CCG, Bristol CCG, Bromley CCG, Bury CCG, Calderdale CCG, Cambridgeshire and Peterborough CCG, Camden CCG, Cannock Chase CCG, Canterbury and Coastal CCG, Castle Point and Rochford CCG, Central London (Westminster) CCG, Central Manchester CCG, Chiltern CCG, Chorley and South Ribble CCG, City and Hackney CCG, Clinical Commissioning Groups (CCGs), Coastal West Sussex CCG, Consultant Focussed Services, Consultant Neurology Outpatient Appointments 2012 to 2013, Corby CCG, Coventry and Rugby CCG, Crawley CCG, Croydon CCG, Cumbria CCG, Darlington CCG, Dartford Gravesham and Swanley CCG, Doncaster CCG, Dorset CCG, Dudley CCG, Durham Dales Easington and Sedgefield CCG, Ealing CCG, East and North Hertfordshire CCG, East Lancashire CCG, East Leicestershire and Rutland CCG, East Midlands, East of England, East Riding of Yorkshire CCG, East Staffordshire CCG, East Surrey CCG, Eastbourne Hailsham and Seaford CCG, Eastern Cheshire CCG, Enfield CCG, Erewash CCG, Fareham and Gosport CCG, Fylde & Wyre CCG, Gateshead CCG, Geographical Variations, Gloucestershire CCG, Great Yarmouth & Waveney CCG, Greater Huddersfield CCG, Greater Preston CCG, Greenwich CCG, Guildford and Waverley CCG, Halton CCG, Hambleton Richmondshire and Whitby CCG, Hammersmith and Fulham CCG, Hardwick CCG, Haringey CCG, Harrogate and Rural District CCG, Harrow CCG, Hartlepool and Stockton-on-Tees CCG, Hastings & Rother CCG, Havering CCG, Herefordshire CCG, Herts Valleys CCG, Heywood Middleton & Rochdale CCG, High Weald Lewes Havens CCG, Hillingdon CCG, Horsham and Mid Sussex CCG, Hounslow CCG, Hull CCG, Ipswich and East Suffolk CCG, Isle of Wight CCG, Islington CCG, John Newton: Chief Knowledge Officer at Public Health England, Kernow CCG, Kingston CCG, Knowsley CCG, Lambeth CCG, Lancashire North CCG, Leeds North CCG, Leeds South and East CCG, Leeds West CCG, Leicester City CCG, Lewisham CCG, Lincolnshire East CCG, Lincolnshire West CCG, Liverpool CCG, Local Adult Neurology Services for Next Decade Report (2011), Local Commissioning, Local Commissioning Groups, Local Neurology Services: Outpatient Analysis, Local Variations, Local Variations in Neurology Outpatient Services, Luton CCG, Mansfield & Ashfield CCG, Medway CCG, Mental Health Dementia and Neurology Intelligence Network (MHDNIN), Mental Health Dementia and Neurology Intelligence Network (MHIN), Mental Health Dementia and Neurology Intelligence Networks, Mental Health Dementia and Neurology ProfilesMental Health Dementia and Neurology Profiles, Mental Health Dementia and Neuroscience (SCN), Merton CCG, Method for Variation Approach, MHDNIN: Mental Health Dementia and Neurology Intelligence Network, Mid Essex CCG, Milton Keynes CCG, National Mental Health Dementia and Neurology Intelligence Networks, Nene CCG, Neurological Alliance, Neurological Datasets, Neurological Disease, Neurological Disorders, Neurology Intelligence Network (NIN), Neurology Outpatient Analysis, Neurology Outpatient Appointments 2012 to 2013 Data, Neurology Outpatient Services, Neurology Outpatient Services in England, Neurology Profiles, Newark & Sherwood CCG, Newbury and District CCG, Newcastle North and East CCG, Newcastle West CCG, Newham CCG, NHS South Lincolnshire CCG, NHS Wyre Forest CCG, Nondegenerative Neurological Diseases (NNDs), North & West Reading CCG, North Derbyshire CCG, North Durham CCG, North East Essex CCG, North East Hampshire and Farnham CCG, North East Lincolnshire CCG, North East West Devon CCG, North Hampshire CCG, North Kirklees CCG, North Lincolnshire CCG, North Manchester CCG, North Norfolk CCG, North Somerset CCG, North Staffordshire CCG, North Tyneside CCG, North West of England, North West Surrey CCG, Northumberland CCG, Norwich CCG, Nottingham City CCG, Nottingham North & East CCG, Nottingham West CCG, Oldham CCG, Oliver Sacks: Author of the book "Awakenings", Oxfordshire CCG, PHE Neurology Intelligence Network (NIN), PHE: Public Health England, Portsmouth CCG, Prevalence of Neurological Conditions, Public Health England (PHE), Public Health England (PHE) Neurology Intelligence Network (NIN), Quality Improvement, Redbridge CCG, Redditch and Bromsgrove CCG, Reducing Variation, Richmond CCG, Rotherham CCG, Royal College of Physicians (RCP), Rushcliffe CCG, Salford CCG, Sandwell and West Birmingham CCG, Scarborough and Ryedale CCG, Sheffield CCG, Shropshire CCG, Slough CCG, Solihull CCG, Somerset CCG, South Cheshire CCG, South Devon and Torbay CCG, South East Coast, South East Staffs and Seisdon Peninsular CCG, South Eastern Hampshire CCG, South Gloucestershire CCG, South Kent Coast CCG, South Lincolnshire CCG, South Manchester CCG, South Norfolk CCG, South Reading CCG, South Sefton CCG, South Tees CCG, South Tyneside CCG, South Warwickshire CCG, South West, South West Lincolnshire CCG, South Worcestershire CCG, Southampton CCG, Southend CCG, Southern Derbyshire CCG, Southport and Formby CCG, Southwark CCG, St Helens CCG, Stafford and Surrounds CCG, Stockport CCG, Stoke on Trent CCG, Strategic Clinical Networks (SCNs), Sunderland CCG, Surrey Downs CCG, Surrey Heath CCG, Sutton CCG, Swale CCG, Swindon CCG, Tameside and Glossop CCG, Telford & Wrekin CCG, Thames Valley, Thanet CCG, Thurrock CCG, Tower Hamlets CCG, Trafford CCG, Unacceptable Variations, Unwarranted Variations, Vale of York CCG, Vale Royal CCG, Variation in Commissioning, Variation in Use of Neurology Diagnostic Services, Variations in Care, Variations in Quality of Care, Variations in Spending, Wakefield CCG, Walsall CCG, Waltham Forest CCG, Wandsworth CCG, Warrington CCG, Warwickshire North CCG, Wessex, West Cheshire CCG, West Essex CCG, West Hampshire CCG, West Kent CCG, West Lancashire CCG, West Leicestershire CCG, West London (K&C & QPP) CCG, West Midlands, West Norfolk CCG, West Suffolk CCG, Wigan Borough CCG, Wiltshire CCG, Windsor Ascot and Maidenhead CCG, Wirral CCG, Wokingham CCG, Wolverhampton CCG, YHPHO	| Leave a comment
Improving Urgent and Emergency Care (NHS Confederation / Urgent and Emergency Care Forum / Emergency Medicine Journal / RCPCH / RCN / RCGP / REF / Health Economics / RCEM)
Summary Based on experiences during Winter 2014/2015, the NHS will encounter a winter crisis in 2015/16. NHS organisations need to plan and act on solutions to help prevent this problem. This NHS Confederation report assembles guidance and recommendations, with examples … Continue reading →
Posted in Acute Hospitals, Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Local Interest, Management of Condition, National, NHS, NHS Confederation, Person-Centred Care, Practical Advice, Quick Insights, RCN, Standards, Statistics, UK, Universal Interest	| Tagged 2015 Challenge: NHS Confederation, 24-Hour Access to Community Services, 24-Hour Community-Based Services, 5YFV: NHS Five Year Forward View, 7 Day Services, 999 and Ambulance See-and-Treat, 999 and Ambulance Treat-and-Convey, A&E, A&E Doctors: Recruitment, A&E Hub, ABCDE Team Triage Process, Access to Primary Care, Access to Urgent and Emergency Care, Accident and Emergency Doctors, Acute Hospital Care, Acutely Sick Kid Safety Netting Interventions for Families (ASK SNIFF), Ageing and Society, Ageing Population, Airedale NHS Foundation Trust, Ambulance Services, Ambulatory Care Units (ACUs), Applied Health Research and Care (CLAHRCs), Assessment and Management, Association of Ambulance Chief Executives (AACE), Attendances at A&E: NHS Local Performance Tracking Service (NHS Winter Project), Attendo Ltd (Helsinki), Avoidable Admissions, Avoidable Emergency Admissions, BBC's NHS Winter Project, Better Health Briefing No. 37, Better Health Briefings, Birmingham Community Healthcare NHS Trust, British Journal of General Practice, Bromley by Bow Health Partnership, C3 Model, Calderdale and Huddersfield NHS Foundation Trust, Cambridge, Cambridgeshire, Cambridgeshire and Peterborough CLAHRC (CLAHRC CP), Care Closer to Home, Cecilia Anim: President of Royal College of Nursing, Child HealthCare Closer to Home (C3), Children and Young People's Health Partnership, Children's Emergency Services, Children's Outreach Assessment and Support Team (COAST), Chronic Diseases, CLAHRC East of England, CLAHRCs: NIHR Collaborations for Leadership in Applied Health Research and Care, Co-Location Models, College of Emergency Medicine (CEM), Community and Health Research Unit (CaHRU): University of Lincoln, Community Care, Community Children's Nurses (CCNs), Community Facilities, Community Wellbeing Practices, Community-Based Services, Complex Care, Complex Needs, Connecting Care for Children (CC4C), Continuity of Care, Coordinated Care, Coordination, Crisis Concordat, Cross Specialty Collaboration, Cross-Boundary Care Pathways, Cultural Competency, De Montfort University, Delayed Transfers of Care, Department of Primary Care and Public Health: Imperial College London, Discharge and Out of Hospital Care, Division of Primary Care: University of Nottingham, DIY Health, Dr Hilary Cass: President of Royal College of Paediatrics and Child Health (RCPCH), Dr Maureen Baker: Chair of Royal College of General Practitioners, East of England, East of England Ambulance Service, EDS1 and EDS2, Electronic Personal Child Health Record (ePCHR), Emergency Admissions, Emergency and Urgent Care Services, Emergency Attendances, Emergency Bed Use, Emergency Care, Emergency Centres, Emergency Departments, Emergency Medical Services (EMS), Emergency Services, Emergency Transport, EMS Roles and Functions in Caring for OPWD, Enhanced Use of Community Nursing, Ethnicity and Pre-Hospital Emergency Care, Evelina Children's Hospital, Extensivist and Primary Care Plus Model, Facing the Future: Standards for Acute General Paediatric Services, Facing the Future: Together for Child Health (2015), Factors Behind Increasing Emergency Admissions, Factors in Increased Use of Urgent and Emergency Care, Faculty of Health and Life Sciences: De Montfort University, Finland, GP and Community Care for Worried Parents, GP Services Co-Located With A&E Department, GPs Co-Located With A&E Department, Guy's and St Thomas' NHS Foundation Trust, Halton Local Authority, Health and Social Care in Northern Ireland, Health Economics, Hear and Treat and See and Treat Services (Reducing A&E Attendances), Helsinki University Central Hospital, HUS: Institute of Clinical Medicine, Imperial Child Health General Practice Hubs, Imperial College Healthcare NHS Trust, Improvements to GP and Community Care, Inappropriate NHS 111 Referrals, Integrated Care Organisation (Merger of Torbay Hospital and Community Health and Care Services), Islington Community Children's Nursing Team (CCNT), Jorvi Hospital, Language Line, Language Line Services (LLS), Last Resort / Safety Net Role(s), Local Commissioning, Local Leadership, Local Right Care2 Plans, Local System Resilience Groups, London Ambulance Service (LAS), London Ambulance Service NHS Foundation Trust, Luton and Dunstable University Hospital NHS Foundation Trust, Manchester Centre for Health Economics: University of Manchester, Mental Health Crisis Care Concordat, Minor Injuries Units, Multidisciplinary Care, Multidisciplinary Research Teams, Multidisciplinary Teams, National Ambulance Commissioner Network (NACN), National Institute for Health and Care Excellence Threshold, NHS 111, NHS Confederation, NHS Confederation's Urgent and Emergency Care Forum, NHS England Emergency and Urgent Care Review, NHS England's Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Halton CCG, NHS Leadership Academy: East Midlands Ambulance Service (EMAS), NHS Tracker Service (BBC's NHS Winter Project), NHS Winter 2014-15: Weekly A&E Tracker, NHS Winter Project (BBC News NHS Tracker Service), NHS Winter Project (BBC News), NHS Winter Project: NHS Local Performance Tracking Service, NICE Cost Effectiveness Threshold, NIHR CLAHRC: Collaboration for Leadership in Applied Health Research and Care, NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRCs), Northern Ireland Electronic Care Record (NIECR), Older People With Dementia (OPWD), Out-of-Hours GP Services Co-Located With A&E Department, PACE SETTER Award, Payment Mechanisms, Personal Health Care Record (PCHR), Prehospital Emergency Care by Ambulance Services, Public Guidance on Division of Work in Emergency Departments, Puolarmetsä Hospital, Race Equality Foundation, Race Equality Foundation (REF), Rapid Response Teams, RCEM and RCN 2016 Summit, RCGP, RCPCH Facing the Future: Standards for Acute General Paediatric Services, Reducing Inappropriate NHS 111 Referrals to 999 and A&E, Reducing Unnecessary Admissions, Reducing Unscheduled Admissions, Reimbursement of Urgent and Emergency Care, Repeat Non-Emergency Attendees (Emergency Departments), Right Care Approach, Right Care2, Robert Lloyd: IHI Executive Director for Performance Improvement, Royal College General Practice (RCGP), Royal College of Emergency Medicine (RCEM), Royal College of Nursing (RCN), Royal College of Paediatrics and Child Health (RCPCH), Scandinavian Journal of Primary Health Care, School of Health and Social Care: University of Lincoln, School of Medicine: University of Nottingham, Self-Care, Seven Day Rapid Response Service (Birmingham Community Healthcare NHS Trust), Seven-Day Services for Emergency Hospital Admissions: Costs Versus Benefits, Solent NHS Trust, South Devon and Torbay CCG, South Devon Healthcare NHS Foundation Trust, South East Coast Ambulance Service (SECAmb), South East Coast Strategic Clinical Network for Children and Young People, South West Ambulance Service Foundation Trust (SWASFT), South West Ambulance Service NHS Foundation Trust, Specialist Professions Based in Ambulance Control Rooms, SRGs: System Resilience Groups, St Mary's Hospital, SWASFT Right Care Right Place Right Time Initiative, System Resilience Groups, System Resilience Groups (SRGs), System-Wide Integration, Transformational Demonstrator Sites, Transforming Urgent and Emergency Care Services, UEC Review: NHS England's Review of Urgent and Emergency Care, UEC Vanguards, UK and East Midlands Ambulance Service (EMAS) NHS Trust, University College London, University of Helsinki, University of Leicester, University of Lincoln, University of Manchester, University of Northampton, University of Nottingham, University of Oxford, Unnecessary Hospital Admissions, Unplanned Hospital Admissions, Unscheduled Admissions, Unscheduled Care Pathways, Urgent and Emergency Care, Urgent and Emergency Care Forum, Urgent and Emergency Care Networks, Urgent and Emergency Care Pathways, Urgent and Emergency Care Review, Urgent and Emergency Care Services, Urgent and Emergency Care Services in England, Urgent and Emergency Care Vanguard Sites, Urgent and Emergency Care Vanguards, Urgent and Emergency Services, Urgent Care Services Outside of Hospitals, Walk-in Centres (WiCs), Wellbeing Enterprises CIC, Whole System Integration, Whole Systems Approach, Whole Systems Redesign, Winter Preparedness, Winter Pressures, Wirral Community NHS Trust, Wrightington Wigan and Leigh NHS Foundation Trust	| Leave a comment
Shape of Caring Review Report (HEE / NMC / BBC News)
Summary Health Education England (HEE) and the Nursing and Midwifery Council (NMC) have published the Shape of Caring Review "Raising the Bar" report, which makes 34 recommendations (grouped into 8 themes) concerning education and training for registered nurses and care … Continue reading →
Posted in Acute Hospitals, Commissioning, Community Care, End of Life Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Health Education England (HEE), In the News, Management of Condition, National, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest	| Tagged BBC Health News, Bridging Programmes for Progression of HCAs and Support Workers into Nursing Programmes, Bridging Programmes: Progression of HCAs and Support Workers into Nursing Programmes, Camilla Cavendish, Care Assistant Mentors, Care Assistants: Education and Training, Career Pathways for HCAs, Cavendish Review, Co-Production, Compassionate Care, Continuing Learning and Development, Delivering Safe and Compassionate Care, Dementia Care, East Midlands, East of England, Education and Training, Education and Training of Registered Nurses and Care Assistants, Education and Training Progression, Education Journey: Care Assistants and Nurses, Embedding Co-Production, Engagement and Co-Production, Engagement and Support (HCAs), Evidence-Based Practice (EBP), Flexibility, Future Care Workforce, Future Workforce, HCAs, HCAs as Part of Nursing Team: Not a Separate Tribe, HCAs: Allegations of HCA Misuse to Plug Gaps in Nursing Workforce, Healthcare Development, HEE: Health Education England, Improving Flexibility of Care, Innovation, Inside Out in the East TV Programme (BBC One), Leadership for Compassionate Care, Learning and Development for Social Care Workers Supporting People with Dementia, London and South West, Lord Willis: Independent Chair of Shape of Caring Review, Mentorship, NHS Workforce, Nursing and Midwifery Council (NMC), Nursing Education, Nursing Workforce, Nursing Workforce Statistics, Ongoing Learning and Development, Patient Voice, Professional Supervision of HCAs, Professional Supervision of HCAs (Inadequate), Raising the Bar: Shape of Caring Review Report, Recruitment Training and Management of HCAs, Registered Nurses: Education and Training, Research, Royal College of Nursing (RCN), Safe Compassionate Care for Frail Older People, Shape of Caring Review "Raising the Bar" Report, Shape of Caring Review Report (2015), Supervising and Leading HCAs, Surrey University: Understanding Dementia, Undergraduate Nursing Education, University of Nottingham: Care Assistant Mentors, Valuing Care and Care Workers, Valuing Care Assistants, West Midlands, Workforce Capacity and Capability, Workforce Competencies, Workforce Development, Workforce Issues, Workforce Planning, Workforce Training	| Leave a comment
Who's Who in the English Regions? (Regional Voices)
Posted on January 6, 2015 by Dementia and Elderly Care News
Summary The regional Voluntary Care Services (VCS) network organisations in England have each updated their "who's who" guide, to help support voluntary and community sector organisations. The aim is to help in contacting people in local health and care organisations, … Continue reading →
Posted in Charitable Bodies, Commissioning, Community Care, For Carers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, National, Practical Advice, Quick Insights, UK, Universal Interest	| Tagged Academic Health Science Network, Birmingham City Council, CCGs, Clinical Senates, Commissioning Support Units, Coventry City Council, CQC, Directors of Adult Services, Directors of Childrens Services, Dudley Metropolitan Borough Council, East Midlands, East of England, Health and Wellbeing Board Representatives, Herefordshire Council, Involve Yorkshire and Humber, JSNA Leads In Local Authorities, Local Authorities, Local HealthWatch, London, London Voluntary Service Council, NHS England Equality Leads, NHS England Local Area Teams, North East, North West, One East Midlands, Public Health, RAISE: Regional Action and Involvement South East, RAWM: Regional Action West Midlands, Regional Voices, Sandwell Metropolitan Borough Council, Scrutiny Leads in Local Authorities, Shropshire City Council, Skills for Care, Solihull Metropolitan Borough Council, South East, South West, South West Forum, Staffordshire County Council, Stoke-on-Trent City Council, Strategic Clinical Networks, Telford & Wrekin City Council, Voluntary and Community Sector, Voluntary and Community Sector (VCS), Voluntary and Community Sector Organisations, Voluntary Care Services, Voluntary Care Services Network, Voluntary Sector North West, VONNE: Voluntary Organisations Network North East, Walsall Metropolitan Borough Council, Warwickshire County Council, Wellbeing East, West Midlands, Who's Who Guides, Who's Who in the Regions (England), Wolverhampton City Council, Worcestershire County Council, Yorkshire and Humber	| Leave a comment
Eleven Genomics Medicine Centres Planned for England (BBC News / Department of Health / NHS England)
Posted on December 22, 2014 by Dementia and Elderly Care News
Summary The NHS has announced further steps in a genetics project, which will involve 11 Genomics Medicine Centres being created in English hospitals to gather DNA information. The aim is to support the 100,000 Genomes Project in research towards the … Continue reading →
Posted in Acute Hospitals, BBC News, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, NHS England, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest	| Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Academic Health Science Networks (AHSNs), Advanced Therapies Facility (QEH), Advanced Therapies Facility: Birmingham NIHR / Wellcome Trust Clinical Research Facility (CRF), BBC Health News, BBC Wales News, Birmingham, Birmingham (UK), Birmingham and the Black Country (Dudley Sandwell Walsall and Wolverhampton), Birmingham CDRC, Birmingham Centre for Clinical Haematology, Birmingham Centre for Clinical Trials (BCCT), Birmingham Children's Hospital, Birmingham City Council, Birmingham City Deal, Birmingham Experimental Arthritis Treatment Centre for Rheumatoid Arthritis (BEAT-RA), Birmingham Health Partners, Birmingham MRC Centre for Immune Regulation, Birmingham NIHR Liver Biomedical Research Unit (BRU), Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK Centre, Cancer Research UK's Stratified Medicine Programme, Cardiff University's MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Centre for Clinical Haematology (CCH), Centre for Endocrinology Diabetes and Metabolism (CEDAM), Centre for Obesity Research, Centre for Translational Inflammation (CTIR), Centre for Translational Inflammation Research (QEH), Chronic Disease Resource Centre (CDRC), City of Sandwell and West Birmingham NHS Foundation Trust, Clinical Research Facility (QEH), Decoding Inherited Disorders, Dementia Research, DNA Extraction, Dudley Group of Hospitals, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Exeter, Experimental Cancer Medicine Centre (ECMC), Genetic Disorders and Genomics, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomic Technologies, Genomics, Genomics England, Genomics in the NHS, Genomics Medicine Centres, Genomics-Based Medicine, Genotyping, George Freeman: Former Life Sciences Minister, Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Health Research Bus (HRB), Health Research Trauma Management Healthcare Technology Co-operative (NIHR Trauma Management HTC), Henry Wellcome Building for Nuclear Magnetic Resonance Facility (HWB-NMR), Herceptin, Human Biomaterials Resource Centre (HBRC), Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Inflammation Research Facility (IRF): NIHR / Wellcome Trust Clinical Research Facility, Innovation, Innovation and Improvement, Innovation in Bioinformatics, Innovation in Biotechnology, Innovation in Genetics, Institute for Translational Medicine in Birmingham, Institute of Translational Medicine (ITM), Institute of Translational Medicine: University of Birmingham, Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Medical Director of NHS England: Professor Sir Bruce Keogh, Microarrays, MRC ARUK Centre for Healthy Ageing, MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH), National Institute for Health Research (NIHR), National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC), Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, NIHR / Wellcome Trust Birmingham Clinical Research Facility (WTCRF), NIHR Clinical Research Facility, NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and the Black Country (NIHR CLAHRC-BBC), NIHR Horizon Scanning Centre, NIHR Translational Research Partnerships (TRPs), North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North West Coast NHS GMC: Liverpool Women's NHS Foundation Trust, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Medicine, Pharmaceutical Industry, Professor David Adams: Dean of Medicine at University of Birmingham Medical School, Professor Mark Caulfield: Chief Scientist at Genomics England, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, QMM: the Student Magazine of the University of Birmingham College of Medical and Dental Sciences, Queen Elizabeth Hospital, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Shape of Training Report, Shape Of Training Review, Sir John Chisholm: Executive Chair of Genomics England, South London NHS GMC: Guy's and St Thomas' NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, Stem Cell Translational Medicine, STXBP1, Targeted Therapies, Translational Research, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham: Cancer Clinical Specialties, University of Birmingham, University of Birmingham Medical School, Wales Infants and Children's Genome Service (Wings), Wellcome Trust Clinical Research Facility, Welsh Government's Genomics for Precision Medicine Strategy (2017), Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands Academic Health Network, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, West Midlands RDS: NIHR Research Design Service (RDS), Whole Genome Sequencing	| Leave a comment
UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)
Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →
Posted in BBC News, Department of Health, Health Education England (HEE), In the News, International, National, NHS, NHS England, Personalisation, Quick Insights, UK, Universal Interest	| Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Aarhus University, Akureyri Hospital (Iceland), Astra Zeneca, BBC Health News, Bioinformatics Research Centre: Aarhus University, Biological Treatments, Biotechnology Companies, Birmingham, Broad Institute / Whitehead Institute (Massachusetts), Bubble-Boy Syndrome (Immune Disorders), Call for Global Moratorium on Clinical Uses of Human Germline Editing, Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK (CRUK), Cas9 (Crispr-Associated Protein 9) Enzyme, Cell and Gene Therapy at Institute of Child Health (ICH), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Chief Scientific Officer Bulletin, Chief Scientific Officer Bulletin (July 2014), Children's Hospital: Landspitali University Hospital (Reykjavik Iceland), Cleveland Clinic, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Collaborative Projects, Collaborative Working, Crispr, Crispr-Cas9, CRISPR-Cas9 Genome Editing System, Crisprs (Clustered Regularly Interspaced Short Palindromic Repeats), Cross-Sector Partnerships, David Cameron, deCODE Genetics, deCODE Genetics /Amgen Inc., Decoding Inherited Disorders, Dementia Research, Denmark, Department of Human Genetics: University of Leuven, Department of Internal Medicine: Akureyri Hospital (Iceland), Dilated Cardiomyopathy, Division of Cardiovascular Diseases: Mayo Clinic, DNA Extraction, Dr Francis Collins: Director of National Institutes of Health (USA), Dr Marcy Darnovsky: Center for Genetics and Society (USA), Drugs Targeted at Specific Mutations, Duke University, East Anglian Medical Genetics Service: Cambridge University Hospitals NHS Foundation Trust, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Elimination of Porcine Endogenous Retroviruses Using Crispr, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Ethical Considerations, Ethical Dilemmas, European Bioinformatics Institute, European Bioinformatics Institute: Wellcome Trust Genome Campus, Exeter, Familial Adenomatous Polyposis (FAP), Foetal Stem Cells, Four Ps of Personalised Medicine: Participatory Role for Patients, Four Ps of Personalised Medicine: Precise Diagnoses, Four Ps of Personalised Medicine: Prediction and Prevention of Disease, Four Ps of Personalised Medicine: Targeted and Personalised Interventions, Francis Crick Institute, Fred and Pamela Buffett Cancer Centre (Omaha), Gene Editing in Mice With Duchenne Muscular Dystrophy, Genetic Disorders and Genomics, Genetic Engineering (Pandora's Box), Genetic Modification of Cells: HIV Treatment Strategy, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genome Campus (Wellcome Trust), Genome Sequencing, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomics, Genomics Education Programme, Genomics Education Programme (HEE), Genomics England, Genomics England's Ethics Advisory Committee, Genomics in the NHS, Genomics-Based Medicine, Genotyping, Germline Alterations (Suggested for DMD Huntington's Disease or Cystic Fibrosis), Germline Editing, Germline Gene Editing, Germline Modification, GM Babies, Great Ormond Street Hospital, Great Ormond Street Hospital (GOSH), Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Harvard University, Health Education England's Genomics Education Programme, HEE: Health Education England, Herceptin, Heritable Human Genome Editing (HHGE), Hinxton Group, Housekeeping Proteins, Human Embryos Edited (August 2017), Human Genetic Disorders, Human Germline Editing, Human Germline Genome Editing (HGGE), Human Protein Atlas, Hypertrophic Cardiomyopathy, IBM Watson Health, IBM's Watson Supercomputer, Iceland, Icelandic Medical Center (Laeknasetrid), IL2RG Gene, Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Improved Prevention Based on Underlying Predisposition, In Utero Stem Cell Therapy, Innovation in Biotechnology, Innovation in Genetics, Innovative Genomics Initiative (University of California in Berkeley / University of California in San Francisco), Institute of Child Health (ICH), International Commission on the Clinical Use of Human Germline Genome Editing, International Summit on Human Gene Editing, Introducing Genomics in Healthcare (Health Education England Video), Knowledge Networks, Knowledge Translation, Knut & Alice Wallenberg Foundation, Knut and Alice Wallenberg Foundation, Laboratory in Mjodd (RAM) Iceland, Landscape of Mutations in Breast Cancer Whole-Genome Sequences, Landspitali University Hospital (Iceland), Large DNA Banks, Large-Scale Whole-Genome Sequencing, Large-Scale Whole-Genome Sequencing (Iceland), Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Lund University, Mayo Clinic (Rochester Minnesota), McDonnell Genome Institute: Washington University (St. Louis), Medical Director of NHS England: Professor Sir Bruce Keogh, Medical Research Council (MRC), Microarrays, Moratorium on Heritable Genome Editing, Mutational Signatures, Mutational Signatures in Breast Cancer, Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres (NHS GMCs), NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North Thames Genomic Medicine Centre, North Thames NHS Genomic Medicine Centre (NHS GMC), North West Coast NHS GMC: Liverpool Women's NHS Foundation Trust, North West London Healthcare Trust, Nuffield Council on Bioethics, OHSU Knight Cardiovascular Institute, Osteogenesis Imperfecta, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Health Care for Cancer, Personalised Medicine, Personalised Medicine Strategy (NHS England), Personalised Medicine Strategy Board, Personalised Medicine Strategy for the NHS, Personalised Medicine: Improving Outcomes, Peter Grainger: Patient and Public Involvement Representative at St Mark's Hospital (North West London Healthcare Trust), Pharmaceutical Industry, PHG Foundation, Prof Peter Braude: King's College London, Professor Ian Cumming OBE: HEE Chief Executive, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, Profiling Individual Cancer Genomes (Personalised Medicine), Protein-Coding Cancer Genes, Radboud University, Regional Genetic Laboratories, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Royal Institute of Technology in Sweden, Sanger Institute, School of Engineering and Natural Sciences, Science Working Group: Cancer, Science Working Group: Infectious Diseases, Science Working Group: Rare Diseases, Small and Medium Enterprises (SMEs), SMEs, Somatic Genetic Basis of Breast Cancer, South London NHS GMC: Guy's and St Thomas' NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, St Mark's Hospital, Sun Yat-sen University in Guangdong (China), Talens, Targeted Drugs, Targeted Therapies, Testes, Thermo Fisher Scientific (Massachusetts), Transformational Elements of NHS Genomic Medicine Centres, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University of Iceland, University of Texas MD Anderson Cancer Center, USA, Viv Parry OBE (Science Broadcaster), Wellcome Trust, Wellcome Trust Sanger Institute, Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, Whole Genome Sequencing, Workforce Competencies, Workforce Development, Workforce Training, Xenotransplantation: Avoiding Shortage of Human Donor Organs, Yale Cancer Centre, Zinc fingers	| Leave a comment
Responsibility for End-of-Life Care in Care Homes Without On-Site Nursing Provision (Nursing Times / Health & Social Care in the Community)
Summary Many care homes in England do not have nurses on site and rely on visits from GPs and district nurses for primary care and referral to specialist services. A recent study examined expectations and experiences of the responsibility for … Continue reading →
Posted in Commissioning, Community Care, End of Life Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, Patient Care Pathway, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, RCN, Standards, UK, Universal Interest	| Tagged Advance Care Planning (ACP), Care Home Staff, Care Homes, Care Homes Without On-Site Nursing Provision, Care Homes: Last Year of Life, Centre for Research in Primary and Community Care: University of Hertfordshire, Community Nurse (Includes District Nursing Sister and District Nurse), Community-Based End of Life Nurse, Decision-Making at End of Life, Department of Public Health and Primary Care: University of Cambridge, East of England, End of Life Care, End of Life Care Discussions, End of Life Care in Care Homes, Good Practice in Care Homes, GPs, Health and Social Care in the Community, Health Care for Older Care Home Residents, Health Care Needs of Care Home Residents, Improving Standards in Care Homes, Kings College London, Lancaster University, Nursing Times, Palliative and End of Life Care, Planning and End of Life Care, Primary Care and Population Health: University College London, Research in Care Homes, Residential Care Homes, Responsibility for End-of-Life Care in Care Homes, Social Care Workforce Research Unit: King's College London, Support to Care Home Residents, Treatment at End of Life, University of Cambridge, University of Hertfordshire, University of Surrey	| Leave a comment
Resources to Reduce Inappropriate Use of Antipsychotics in Dementia (UKMi / East & South East England Specialist Pharmacy Services)
Summary This document assembles a collection of resources to support primary and secondary care pharmacists in reducing the inappropriate use of antipsychotics for patients showing Behavioural and Psychological Symptoms of Dementia (BPSD). The resources are based on the "Medicines Use … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest	| Tagged Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Audit of Antipsychotic Prescribing in Dementia Patients, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural Alternatives to Antipsychotic Drugs, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Call to Action on Antipsychotic Drugs (Dementia Action Alliance), CPPE, Dementia Action Alliance, Dementia Action Alliance (DAA), East & South East England Specialist Pharmacy Services, East of England, Health and Social Care Information Centre, Inappropriate Use of Antipsychotics in Dementia, London, London Antipsychotics Audit and Reduction Exercise in Primary Care, Management of Medicines, Medicines and Falls in Hospital, Medicines for Elderly Linked to Dementia, Medicines Management, Medicines Use and Safety Secondary Care Workshop, National Audit of Dementia Care in Hospitals, National Dementia and Antipsychotic Prescribing Audit 2012, National Prescribing Centre, National Prescribing Service: Australia, NHS London, NHS London: Medicines Use and Safety Team, NHS Sussex, Pharmacists, Prescribing of Antipsychotic Drugs For People With Dementia, Professor Sube Banerjee, Psychological Symptoms of Dementia (BPSD), Reducing Inappropriate Use of Antipsychotics in Dementia, Right Prescription (Dementia Action Alliance), Royal Pharmaceutical Society, Safeguarding and Medicines, South Central & South East Coast, Southampton City NHS Trust, Sussex Partnership NHS Trust, UKMi, Underlying Causes of BPSD	| Leave a comment